×
Log in
Upload File
Most Popular
Art & Photos
Automotive
Business
Career
Design
Education
Hi-Tech
+ Browse for More
The top documents tagged [nida slide]
Documents
Extended Release Naltrexone: Current Evidence Joshua D. Lee MD MSc
[email protected]
Assistant Professor NYU School of Medicine NYSAM, NY, NY FEB 5
215 views
Documents
1 Training and Career Development Applications & Funding: Perspectives from the National Institutes of Health – NIH and the The National Institute on Drug
219 views
Documents
By Arthur Dryver, PhD 1 and Wasita Boonsathorn, PhD 2 1 Graduate School of Business Administration, NIDA Email:
[email protected]
URL: @gmail.com
215 views
Documents
A Research-Based Campaign to Educate All Sectors of the Community about the Dangers of Youth Marijuana Use
215 views
Documents
Chapter 15 Hallucinogen Abuse and Addiction. What are hallucinogens? Hallucinogens are drugs that cause hallucinations - profound distortions in a person's
221 views
Documents
Medications For The Treatment Of Opiate Dependence In The US Current Therapies And New Developments WHO Meeting April 2002 Ahmed Elkashef, M.D. Clinical
215 views
Documents
NA shell NA shell vPFC mVP VTA NA core NA core dPFC SN dVP Blockade in these regions blocks relapse or reinstatement Drug Seeking Behavior – Motor Subcircuit
216 views
Documents
The Neurobiology of Drug Addiction The Neurobiology of Drug Addiction Glen R. Hanson, Ph.D., D.D.S. Director, Utah Addiction Center Professor of Pharmacology
232 views
Documents
Sakai as a Virtual Research Environment Dr. Charles Severance Clinical Assistant Professor University of Michigan School of Information
[email protected]
226 views
Documents
1 Kim Edward Light, Ph.D. Professor, College of Pharmacy University of Arkansas for Medical Sciences The Neurobiology of Addiction
216 views
Documents
Neonatal Death Associated with Maternal Methamphetamine Abuse Susan R. Howe, PhD Joyce Y. Ho, BS Carl Wigren, MD December, 2006
216 views
Documents
Exploration of Endpoints for Pivotal Clinical Trials to Treat AUD Raye Z. Litten, Ph.D. Daniel Falk, Ph.D. (Discussant) Division of Treatment and Recovery
214 views
Next >